Cargando…
Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses
Highly pathogenic avian influenza represents a severe public health threat. Over the last decade, the demand for highly efficacious vaccines against avian influenza viruses has grown, especially after the 2013 H7N9 outbreak in China that resulted in over 600 human cases with over 200 deaths. Current...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546595/ https://www.ncbi.nlm.nih.gov/pubmed/28787006 http://dx.doi.org/10.1371/journal.pone.0182683 |